| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1036221931 |
| P356 | DOI | 10.1038/NG2003 |
| P3181 | OpenCitations bibliographic resource ID | 985759 |
| P698 | PubMed publication ID | 17401365 |
| P5875 | ResearchGate publication ID | 51383068 |
| P2093 | author name string | Golub TR | |
| Jacks T | |||
| Kumar MS | |||
| Lu J | |||
| Mercer KL | |||
| P2860 | cites work | Human MicroRNA targets | Q21563637 |
| The RNaseIII enzyme Dicer is required for morphogenesis but not patterning of the vertebrate limb | Q24534375 | ||
| Sequence-specific inhibition of microRNA- and siRNA-induced RNA silencing | Q24537549 | ||
| A microRNA expression signature of human solid tumors defines cancer gene targets | Q24541455 | ||
| Cre-lox-regulated conditional RNA interference from transgenes | Q24564248 | ||
| Extensive post-transcriptional regulation of microRNAs and its implications for cancer | Q24672862 | ||
| Sequence-specific inhibition of small RNA function | Q24797869 | ||
| RAS is regulated by the let-7 microRNA family | Q27860522 | ||
| A microRNA polycistron as a potential human oncogene | Q27860720 | ||
| A system for stable expression of short interfering RNAs in mammalian cells | Q27860875 | ||
| c-Myc-regulated microRNAs modulate E2F1 expression | Q27861046 | ||
| MicroRNAs: genomics, biogenesis, mechanism, and function | Q27861070 | ||
| MicroRNA expression profiles classify human cancers | Q28032481 | ||
| Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma | Q28260227 | ||
| A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation | Q28280072 | ||
| High expression of ligands for chemokine receptor CXCR2 in alveolar epithelial neoplasia induced by oncogenic kras | Q28511056 | ||
| Dicer-deficient mouse embryonic stem cells are defective in differentiation and centromeric silencing | Q28594776 | ||
| siRNAs can function as miRNAs | Q29615070 | ||
| The profile of repeat-associated histone lysine methylation states in the mouse epigenome | Q33868292 | ||
| Characterization of Dicer-deficient murine embryonic stem cells. | Q33916756 | ||
| Targeted disruption of the three Rb-related genes leads to loss of G(1) control and immortalization | Q35207910 | ||
| MicroRNA biogenesis and cancer | Q36113847 | ||
| Transcriptional regulation and transformation by Myc proteins | Q36215755 | ||
| Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras | Q40424687 | ||
| Somatic activation of the K-ras oncogene causes early onset lung cancer in mice | Q40809826 | ||
| Reduced expression of Dicer associated with poor prognosis in lung cancer patients. | Q43573248 | ||
| An oncogenic KRAS2 expression signature identified by cross-species gene-expression analysis | Q47608135 | ||
| Endogenous oncogenic K-ras(G12D) stimulates proliferation and widespread neoplastic and developmental defects. | Q47745236 | ||
| The differential effects of mutant p53 alleles on advanced murine lung cancer | Q81480859 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | microRNA | Q310899 |
| P304 | page(s) | 673-7 | |
| P577 | publication date | 2007-05-01 | |
| P1433 | published in | Nature Genetics | Q976454 |
| P1476 | title | Impaired microRNA processing enhances cellular transformation and tumorigenesis | |
| P478 | volume | 39 |
| Q36436094 | 1,25-Dihydroxyvitamin D3 suppresses telomerase expression and human cancer growth through microRNA-498. |
| Q35683457 | 3'-UTR Polymorphisms in the MiRNA Machinery Genes DROSHA, DICER1, RAN, and XPO5 Are Associated with Colorectal Cancer Risk in a Korean Population |
| Q64275042 | 5p and 3p Strands of miR-34 Family Members Have Differential Effects in Cell Proliferation, Migration, and Invasion in Cervical Cancer Cells |
| Q58105685 | 6mer seed toxicity in tumor suppressive microRNAs |
| Q36619943 | A Myc-microRNA network promotes exit from quiescence by suppressing the interferon response and cell-cycle arrest genes. |
| Q57173888 | A comprehensive evaluation for polymorphisms in family in cancer risk and prognosis: a system review and meta-analysis |
| Q37565007 | A dosage-dependent pleiotropic role of Dicer in prostate cancer growth and metastasis |
| Q24303520 | A genetic defect in exportin-5 traps precursor microRNAs in the nucleus of cancer cells |
| Q45136934 | A genetic variant in miR-146a modifies colorectal cancer susceptibility in a Chinese population |
| Q84229513 | A genetic variant in microRNA-196a2 is associated with increased cancer risk: a meta-analysis |
| Q28284233 | A let-7 MicroRNA-sensitive vesicular stomatitis virus demonstrates tumor-specific replication |
| Q43666067 | A low Dicer expression is associated with resistance to 5-FU-based chemoradiotherapy and a shorter overall survival in patients with oral squamous cell carcinoma |
| Q21135329 | A micro RNA processing defect in rapidly progressing idiopathic pulmonary fibrosis |
| Q92559936 | A microRNA signature of toxic extrasynaptic N-methyl-D-aspartate (NMDA) receptor signaling |
| Q34041778 | A mouse polyomavirus-encoded microRNA targets the cellular apoptosis pathway through Smad2 inhibition |
| Q38994476 | A network-biology perspective of microRNA function and dysfunction in cancer |
| Q35156184 | A new polymorphism biomarker rs629367 associated with increased risk and poor survival of gastric cancer in chinese by up-regulated miRNA-let-7a expression |
| Q34529173 | A novel DICER1 mutation identified in a female with ovarian Sertoli-Leydig cell tumor and multinodular goiter: a case report |
| Q34983995 | A novel immunocompetent murine model for replicating oncolytic adenoviral therapy |
| Q34997135 | A novel microRNA mmu-miR-466h affects apoptosis regulation in mammalian cells |
| Q34103961 | A polymorphism of microRNA196a genome region was associated with decreased risk of glioma in Chinese population |
| Q26740327 | A potential role for estrogen in cigarette smoke-induced microRNA alterations and lung cancer |
| Q42086195 | A precursor microRNA in a cancer cell nucleus: get me out of here! |
| Q37353829 | A risk variant in an miR-125b binding site in BMPR1B is associated with breast cancer pathogenesis. |
| Q37403741 | A study of microRNAs in silico and in vivo: diagnostic and therapeutic applications in cancer |
| Q90198382 | A thiosemicarbazone derivative induces triple negative breast cancer cell apoptosis: possible role of miRNA-125a-5p and miRNA-181a-5p |
| Q35079974 | ADAR2-mediated editing of miR-214 and miR-122 precursor and antisense RNA transcripts in liver cancers |
| Q38041704 | Aberrations in the micro-RNA biogenesis machinery and the emerging roles of micro-RNAs in the pathogenesis of cutaneous malignant melanoma |
| Q38770496 | Alternative splicing affects the subcellular localization of Drosha |
| Q52643918 | An NF90/NF110-mediated feedback amplification loop regulates dicer expression and controls ovarian carcinoma progression. |
| Q37978772 | An evolving model of hematopoietic stem cell functional identity |
| Q21245772 | An integrative genomic analysis revealed the relevance of microRNA and gene expression for drug-resistance in human breast cancer cells |
| Q39461997 | An oncogenic role of miR-142-3p in human T-cell acute lymphoblastic leukemia (T-ALL) by targeting glucocorticoid receptor-α and cAMP/PKA pathways |
| Q38944047 | An update on the epigenetics of glioblastomas |
| Q64996867 | Analysis of Expression Patterns of MicroRNAs That Are Closely Associated With Renal Carcinogenesis. |
| Q24647302 | Analysis of deep sequencing microRNA expression profile from human embryonic stem cells derived mesenchymal stem cells reveals possible role of let-7 microRNA family in downstream targeting of hepatic nuclear factor 4 alpha |
| Q91676732 | Androgen receptor-modulatory microRNAs provide insight into therapy resistance and therapeutic targets in advanced prostate cancer |
| Q39644288 | Androgen regulation of micro-RNAs in prostate cancer |
| Q42323692 | Annexin-1-mediated endothelial cell migration and angiogenesis are regulated by vascular endothelial growth factor (VEGF)-induced inhibition of miR-196a expression |
| Q39678660 | Antagonistic role of hnRNP A1 and KSRP in the regulation of let-7a biogenesis. |
| Q33611616 | Anti-Argonaute RIP-Chip shows that miRNA transfections alter global patterns of mRNA recruitment to microribonucleoprotein complexes |
| Q39011476 | Anti-cancer therapeutic potential of quinazoline based small molecules via global upregulation of miRNAs. |
| Q24616200 | Ascl1a regulates Müller glia dedifferentiation and retinal regeneration through a Lin-28-dependent, let-7 microRNA signalling pathway |
| Q47420452 | Association between SNPs in microRNA machinery genes and gastric cancer susceptibility, invasion, and metastasis in Chinese Han population |
| Q58856556 | Association between a functional polymorphism rs712 within let-7-binding site and risk of papillary thyroid cancer |
| Q36246654 | Association between common genetic variants in pre-microRNAs and the clinicopathological characteristics and survival of gastric cancer patients |
| Q35644369 | Association between microRNA196a2 rs11614913 genotypes and the risk of non-small cell lung cancer in Korean population |
| Q36356526 | Association of Polymorphic Variants of miRNA Processing Genes with Larynx Cancer Risk in a Polish Population |
| Q52589147 | Association of microRNA biosynthesis genes DROSHA and DGCR8 polymorphisms with cancer susceptibility: a systematic review and meta-analysis. |
| Q39366349 | BRCA1 regulates microRNA biogenesis via the DROSHA microprocessor complex |
| Q58283916 | Barcoded cDNA Libraries for miRNA Profiling by Next-Generation Sequencing |
| Q36429533 | Barcoded cDNA library preparation for small RNA profiling by next-generation sequencing |
| Q39281568 | Bladder cancer: Micro RNAs as biomolecules for prognostication and surveillance |
| Q34105744 | Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia. |
| Q34488883 | CD44 promotes Kras-dependent lung adenocarcinoma |
| Q24594739 | Cancer microRNAs: from subtype profiling to predictors of response to therapy |
| Q33903791 | Cancer models in Caenorhabditis elegans |
| Q37920789 | Cancer stem cell theory in gastrointestinal malignancies: recent progress and upcoming challenges |
| Q36111468 | Caspases cleave and inhibit the microRNA processing protein DiGeorge Critical Region 8. |
| Q33805554 | Celecoxib increases miR-222 while deterring aromatase-expressing breast tumor growth in mice |
| Q34975000 | Cell-cell contact globally activates microRNA biogenesis. |
| Q21245716 | Centrosome-associated regulators of the G(2)/M checkpoint as targets for cancer therapy |
| Q33808368 | Characterization of MicroRNA-200 pathway in ovarian cancer and serous intraepithelial carcinoma of fallopian tube. |
| Q36409649 | Characterization of a set of tumor suppressor microRNAs in T cell acute lymphoblastic leukemia |
| Q28473165 | Characterization of the Melanoma miRNAome by Deep Sequencing |
| Q50480526 | Chemoresistance in ovarian cancer linked to expression of microRNAs. |
| Q24683729 | Chromosomal rearrangements and microRNAs: a new cancer link with clinical implications |
| Q34406179 | Cigarette smoking decreases global microRNA expression in human alveolar macrophages |
| Q33666711 | Circular reasoning: microRNAs and cell-cycle control |
| Q28081347 | Circulating microRNAs: potential biomarkers for common malignancies |
| Q41138762 | Co-expression Pattern Analysis of miR-17-92 Target Genes in Chronic Myelogenous Leukemia |
| Q36677802 | Cobalt(III) Protoporphyrin Activates the DGCR8 Protein and Can Compensate microRNA Processing Deficiency |
| Q58802479 | Combination of a six microRNA expression profile with four clinicopathological factors for response prediction of systemic treatment in patients with advanced colorectal cancer |
| Q35110766 | Combinations of serum prostate-specific antigen and plasma expression levels of let-7c, miR-30c, miR-141, and miR-375 as potential better diagnostic biomarkers for prostate cancer |
| Q37210703 | Combined expression of miR-34a and Smac mediated by oncolytic vaccinia virus synergistically promote anti-tumor effects in Multiple Myeloma |
| Q36156276 | Common genetic polymorphisms in pre-microRNAs and risk of bladder cancer |
| Q53284479 | Common genetic polymorphisms of microRNA biogenesis pathway genes and risk of breast cancer: a case-control study in Korea. |
| Q34797216 | Common genetic variants in pre-microRNAs were associated with increased risk of breast cancer in Chinese women |
| Q34734182 | Comparison of microRNA deep sequencing of matched formalin-fixed paraffin-embedded and fresh frozen cancer tissues |
| Q35461584 | Comprehensive analysis of clinical significance of stem-cell related factors in renal cell cancer |
| Q37189572 | Comprehensive analysis of microRNA (miRNA) targets in breast cancer cells |
| Q39977932 | Comprehensive analysis of the impact of SNPs and CNVs on human microRNAs and their regulatory genes |
| Q34614754 | Concordant and discordant regulation of target genes by miR-31 and its isoforms |
| Q34217241 | Connective tissue growth factor modulates oral squamous cell carcinoma invasion by activating a miR-504/FOXP1 signalling. |
| Q38111225 | Control of metastatic progression by microRNA regulatory networks |
| Q36350416 | Coordinated loss of microRNA group causes defenseless signaling in malignant lymphoma. |
| Q42243553 | Copy number abnormalities, MYC activity, and the genetic fingerprint of normal B cells mechanistically define the microRNA profile of diffuse large B-cell lymphoma |
| Q33627871 | Coupling transcriptional and post-transcriptional miRNA regulation in the control of cell fate. |
| Q36866858 | CpG island hypermethylation-associated silencing of microRNAs promotes human endometrial cancer |
| Q36073979 | Cross talk between microRNA and coding cancer genes. |
| Q41872966 | Crosstalk between p53 and TGF-β Signalling. |
| Q53302549 | Curcumin regulates miR-21 expression and inhibits invasion and metastasis in colorectal cancer. |
| Q35866113 | Curcumin: updated molecular mechanisms and intervention targets in human lung cancer |
| Q36517492 | Current status and implications of microRNAs in ovarian cancer diagnosis and therapy |
| Q27028008 | Current understanding of the role of microRNAs in spinocerebellar ataxias |
| Q37417571 | Cyclin D1 induction of Dicer governs microRNA processing and expression in breast cancer. |
| Q42114708 | DGCR8 is essential for tumor progression following PTEN loss in the prostate |
| Q34002213 | DGCR8 recognizes primary transcripts of microRNAs through highly cooperative binding and formation of higher-order structures |
| Q45040306 | DGCR8-mediated disruption of miRNA biogenesis induces cellular senescence in primary fibroblasts. |
| Q37636641 | DICER governs characteristics of glioma stem cells and the resulting tumors in xenograft mouse models of glioblastoma |
| Q24629110 | DICER1 mutations in familial multinodular goiter with and without ovarian Sertoli-Leydig cell tumors |
| Q53259152 | DICER1, DROSHA and miRNAs in patients with non-small cell lung cancer: implications for outcomes and histologic classification. |
| Q34404772 | DICER1-pleuropulmonary blastoma familial tumor predisposition syndrome: a unique constellation of neoplastic conditions |
| Q38245164 | DICER1: mutations, microRNAs and mechanisms |
| Q34475613 | Deciphering squamous cell carcinoma using multidimensional genomic approaches |
| Q36191422 | Deciphering the RNA landscape by RNAome sequencing |
| Q91987733 | Deep sequencing reveals two Jurkat subpopulations with distinct miRNA profiles during camptothecin-induced apoptosis |
| Q39105456 | Defective DROSHA processing contributes to downregulation of MiR-15/-16 in chronic lymphocytic leukemia |
| Q90554244 | Deficiency of DICER reduces the invasion ability of trophoblasts and impairs the pro-angiogenic effect of trophoblast-derived microvesicles |
| Q34091328 | Deregulation of microRNA expression in the different genetic subtypes of multiple myeloma and correlation with gene expression profiling. |
| Q33879720 | Developmental programming of fetal skeletal muscle and adipose tissue development |
| Q26748767 | Diagnostic value of microRNAs in asbestos exposure and malignant mesothelioma: systematic review and qualitative meta-analysis |
| Q36925015 | Dicer Gene Expression as a Prognostic Factor in Acute Lymphoblastic Leukemia and Chronic Lymphocytic Leukemia in Fars Province |
| Q38766652 | Dicer expression in estrogen receptor-positive versus triple-negative breast cancer: an antibody comparison |
| Q36974299 | Dicer functions as an antiviral system against human adenoviruses via cleavage of adenovirus-encoded noncoding RNA |
| Q36870468 | Dicer interacts with SIRT7 and regulates H3K18 deacetylation in response to DNA damaging agents. |
| Q39086355 | Dicer is down-regulated in clear cell renal cell carcinoma and in vitro Dicer knockdown enhances malignant phenotype transformation |
| Q37183825 | Dicer is regulated by cellular stresses and interferons |
| Q41642286 | Dicer loss and recovery induce an oncogenic switch driven by transcriptional activation of the oncofetal Imp1-3 family |
| Q35161464 | Dicer regulates differentiation and viability during mouse pancreatic cancer initiation |
| Q40045747 | Dicer regulates non-homologous end joining and is associated with chemosensitivity in colon cancer patients. |
| Q37109737 | Dicer suppresses the malignant phenotype in VHL-deficient clear cell renal cell carcinoma by inhibiting HIF-2α. |
| Q36882995 | Dicer-dependent pathways regulate chondrocyte proliferation and differentiation |
| Q42648408 | Dicer-independent, Ago2-mediated microRNA biogenesis in vertebrates |
| Q37457958 | Dicer1 functions as a haploinsufficient tumor suppressor |
| Q64069801 | Dietary Lutein Plus Zeaxanthin Intake and DICER1 rs3742330 A > G Polymorphism Relative to Colorectal Cancer Risk |
| Q52602656 | Different sized somatic NF1 locus rearrangements in neurofibromatosis 1-associated malignant peripheral nerve sheath tumors. |
| Q21134708 | Differential expression of miRNAs in colorectal cancer: comparison of paired tumor tissue and adjacent normal mucosa using high-throughput sequencing |
| Q64066128 | Differential expression of microRNA-411 and 376c is associated with hypertension in pregnancy |
| Q36289106 | Differentiation-associated microRNAs antagonize the Rb-E2F pathway to restrict proliferation. |
| Q36791139 | Direct detection and quantification of microRNAs |
| Q35197463 | Disruption of Dicer1 induces dysregulated fetal gene expression and promotes hepatocarcinogenesis |
| Q34974250 | Disruption of microRNA biogenesis confers resistance to ER stress-induced cell death upstream of the mitochondrion |
| Q38172138 | Disruption of the expression and function of microRNAs in lung cancer as a result of epigenetic changes |
| Q38917575 | Down regulation of miR-202 modulates Mxd1 and Sin3A repressor complexes to induce apoptosis of pancreatic cancer cells |
| Q34312220 | Down-regulation of MiR-127 facilitates hepatocyte proliferation during rat liver regeneration |
| Q36413232 | Down-regulation of c-Met and Bcl2 by microRNA-206, activates apoptosis, and inhibits tumor cell proliferation, migration and colony formation |
| Q43697314 | Down-regulation of miR-150 induces cell proliferation inhibition and apoptosis in non-small-cell lung cancer by targeting BAK1 in vitro |
| Q24655144 | Down-regulation of micro-RNA-1 (miR-1) in lung cancer. Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis by miR-1 |
| Q38864753 | Down-regulation of microRNA-26b modulates non-small cell lung cancer cells chemoresistance and migration through the association of PTEN. |
| Q46206014 | Down-regulation of the microRNA processing enzyme Dicer is a prognostic factor in human colorectal cancer |
| Q44501009 | Downregulated Dicer expression predicts poor prognosis in chronic lymphocytic leukemia |
| Q46269102 | Downregulation of Dicer expression by serum withdrawal sensitizes human endothelial cells to apoptosis |
| Q39236863 | Downregulation of miR-153 contributes to epithelial-mesenchymal transition and tumor metastasis in human epithelial cancer |
| Q38937139 | Downregulation of miR-25 modulates non-small cell lung cancer cells by targeting CDC42. |
| Q33937702 | Downregulation of microRNA miR-520h by E1A contributes to anticancer activity |
| Q39196781 | Downregulation of the microRNA biogenesis components and its association with poor prognosis in hepatocellular carcinoma |
| Q36333354 | Drosha regulates hMSCs cell cycle progression through a miRNA independent mechanism. |
| Q91834971 | Dual mechanism of DICER downregulation facilitates cancer metastasis |
| Q37626798 | Dynamic regulation of uncoupling protein 2 expression by microRNA-214 in hepatocellular carcinoma |
| Q37770965 | Dynamics of microRNA biogenesis: crosstalk between p53 network and microRNA processing pathway. |
| Q53466891 | Dysregulated expression of Dicer in invasive ductal breast carcinoma. |
| Q36069392 | Dysregulated miR-645 affects the proliferation and invasion of head and neck cancer cell |
| Q38381897 | Dysregulation of microRNA biogenesis and gene silencing in cancer |
| Q26766173 | Dysregulation of microRNA biogenesis in cancer: the impact of mutant p53 on Drosha complex activity |
| Q37580463 | Dysregulation of microRNA biogenesis machinery in cancer |
| Q37779828 | Dysregulation of microRNAs in cancer: playing with fire |
| Q35015916 | E2F1-inducible microRNA 449a/b suppresses cell proliferation and promotes apoptosis |
| Q40008366 | EGFR regulation by microRNA in lung cancer: correlation with clinical response and survival to gefitinib and EGFR expression in cell lines |
| Q42396355 | EGFR signaling pathway and related-miRNAs in age-related diseases: the example of miR-221 and miR-222. |
| Q37285463 | EGFR signals downregulate tumor suppressors miR-143 and miR-145 in Western diet-promoted murine colon cancer: role of G1 regulators |
| Q35999401 | EMT and induction of miR-21 mediate metastasis development in Trp53-deficient tumours |
| Q34236524 | Editing of Epstein-Barr virus-encoded BART6 microRNAs controls their dicer targeting and consequently affects viral latency |
| Q99711397 | Effect of Brivaracetam on Efficacy and Tolerability in Patients With Brain Tumor-Related Epilepsy: A Retrospective Multicenter Study |
| Q28742014 | Effect of Xpcl1 activation and p27(Kip1) loss on gene expression in murine lymphoma |
| Q34674523 | Effects of common polymorphism rs11614913 in Hsa-miR-196a2 on lung cancer risk |
| Q50650541 | Effects of four single nucleotide polymorphisms in microRNA-coding genes on lung cancer risk. |
| Q37407342 | Effects of microRNA-21 on the biological functions of T-cell acute lymphoblastic lymphoma/leukemia |
| Q35092050 | Elevated expression of prostate cancer-associated genes is linked to down-regulation of microRNAs |
| Q36885404 | Embryonic stem cells: from bench to bedside. |
| Q37264369 | Emerging roles of competing endogenous RNAs in cancer: insights from the regulation of PTEN |
| Q37272418 | Emerging roles of microRNAs as molecular switches in the integrated circuit of the cancer cell. |
| Q34109542 | Emerging roles of microRNAs in the control of embryonic stem cells and the generation of induced pluripotent stem cells |
| Q37211627 | Endocrine resistance in breast cancer: Current status and a perspective on the roles of miRNAs (Review). |
| Q54976490 | Endogenous Control Mechanisms of FAK and PYK2 and Their Relevance to Cancer Development. |
| Q29617352 | Endogenous human microRNAs that suppress breast cancer metastasis |
| Q36548746 | Endothelial Dicer promotes atherosclerosis and vascular inflammation by miRNA-103-mediated suppression of KLF4 |
| Q34165233 | Epigenetic inactivation of microRNA-34b/c predicts poor disease-free survival in early-stage lung adenocarcinoma. |
| Q38544386 | Epigenetic mechanisms and therapeutic targets of chemotherapy resistance in epithelial ovarian cancer |
| Q38189740 | Epigenetics and cervical cancer: from pathogenesis to therapy |
| Q35039281 | Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy |
| Q24598045 | Epigenetics of colorectal cancer |
| Q37583650 | Epigenetics, miRNAs, and human cancer: a new chapter in human gene regulation |
| Q37629548 | Epigenomic Regulation of Androgen Receptor Signaling: Potential Role in Prostate Cancer Therapy |
| Q46780498 | Ethnicity modifies the association between functional microRNA polymorphisms and breast cancer risk: a HuGE meta-analysis |
| Q37956184 | Eukaryotic DNA damage checkpoint activation in response to double-strand breaks |
| Q45860362 | Evaluation of genetic variants in microRNA biosynthesis genes and risk of breast cancer in Chinese women |
| Q37144092 | Everything you wanted to know about small RNA but were afraid to ask. |
| Q55397409 | Expansion of cat-ELCCA for the Discovery of Small Molecule Inhibitors of the Pre-let-7-Lin28 RNA-Protein Interaction. |
| Q38764098 | Exploiting microRNAs As Cancer Therapeutics |
| Q54319566 | Exploring microRNA-mediated alteration of EGFR signaling pathway in non-small cell lung cancer using an mRNA:miRNA regression model supported by target prediction databases. |
| Q36751314 | Exploring the RNA world in hematopoietic cells through the lens of RNA-binding proteins. |
| Q55260540 | Exploring the microRNA profiles as potential diagnostic probes for oligo- and polymetastatic prognosis of lung metastasis(es) patients. |
| Q46291987 | Expression of both poly r(C) binding protein 1 (PCBP1) and miRNA-3978 is suppressed in peritoneal gastric cancer metastasis |
| Q37698895 | Extensive sequence variation in the 3' untranslated region of the KRAS gene in lung and ovarian cancer cases |
| Q34270516 | Extent, causes, and consequences of small RNA expression variation in human adipose tissue |
| Q36472462 | FSH stimulates expression of the embryonic gene HMGA2 by downregulating let-7 in normal fimbrial epithelial cells of ovarian high-grade serous carcinomas |
| Q34591159 | Five microRNAs in plasma as novel biomarkers for screening of early-stage non-small cell lung cancer |
| Q44675482 | Four common polymorphisms in microRNAs and the risk of adult glioma in a Chinese case-control study |
| Q53272922 | From Benchtop to Bedside: A Review of Oncolytic Virotherapy. |
| Q37884235 | From microRNAs to targets: pathway discovery in cell fate transitions |
| Q57065888 | Functional Role of microRNAs in the Progression of Breast Ductal Carcinoma in situ |
| Q38951546 | Functional analysis of miR-34c as a putative tumor suppressor in high-grade serous ovarian cancer |
| Q37125039 | Functional integration of microRNAs into oncogenic and tumor suppressor pathways |
| Q34794055 | Functional polymorphisms in two pre-microRNAs and cancer risk: a meta-analysis |
| Q41082813 | Functional screen analysis reveals miR-3142 as central regulator in chemoresistance and proliferation through activation of the PTEN-AKT pathway in CML. |
| Q60044568 | Gene code CD274/PD-L1: from molecular basis toward cancer immunotherapy |
| Q34797283 | Genetic and epigenetic association studies suggest a role of microRNA biogenesis gene exportin-5 (XPO5) in breast tumorigenesis. |
| Q53061705 | Genetic association of gastric cancer with miRNA clusters including the cancer-related genes MIR29, MIR25, MIR93 and MIR106: results from the EPIC-EURGAST study. |
| Q37010620 | Genetic modification of stem cells for transplantation |
| Q34078876 | Genetic polymorphisms in MicroRNA-related genes as predictors of clinical outcomes in colorectal adenocarcinoma patients |
| Q48142966 | Genetic polymorphisms of microRNA machinery genes predict overall survival of esophageal squamous carcinoma. |
| Q37309427 | Genetic variants in RAN, DICER and HIWI of microRNA biogenesis genes and risk of cervical carcinoma in a Chinese population |
| Q38320831 | Genetic variants in the integrin gene predicted microRNA-binding sites were associated with the risk of prostate cancer |
| Q36081357 | Genetic variants in the microRNA machinery gene GEMIN4 are associated with risk of prostate cancer: a case-control study of the Chinese Han population |
| Q24648054 | Genetic variants of miRNA sequences and non-small cell lung cancer survival |
| Q53291654 | Genetic variants within miR-126 and miR-335 are not associated with breast cancer risk. |
| Q36808372 | Genetic variation in MicroRNA genes and risk of oral premalignant lesions |
| Q34177121 | Genetic variation in microRNA networks: the implications for cancer research |
| Q53260732 | Genetic variations in miR-27a gene decrease mature miR-27a level and reduce gastric cancer susceptibility. |
| Q36813961 | Genetic variations in micro-RNA biogenesis genes and clinical outcomes in non-muscle-invasive bladder cancer |
| Q34920257 | Genetic variations in microRNA-related genes are novel susceptibility loci for esophageal cancer risk |
| Q44326528 | Genetic variations of microRNAs in human cancer and their effects on the expression of miRNAs |
| Q37345130 | Genetically modified mouse models in cancer studies |
| Q33504171 | Genomic analysis suggests that mRNA destabilization by the microprocessor is specialized for the auto-regulation of Dgcr8 |
| Q36657641 | Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer |
| Q34803786 | Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer |
| Q26751068 | Genomics, microRNA, epigenetics, and proteomics for future diagnosis, treatment and monitoring response in upper GI cancers |
| Q33671775 | Global microRNA depletion suppresses tumor angiogenesis. |
| Q43047465 | Global microRNA expression is essential for murine mast cell development in vivo |
| Q47282038 | HIF-1α promotes autophagic proteolysis of Dicer and enhances tumor metastasis. |
| Q90619761 | HIV-1 Nef promotes cell proliferation and microRNA dysregulation in lung cells |
| Q64008514 | HMGA2 promotes long-term engraftment and myeloerythroid differentiation of human hematopoietic stem and progenitor cells |
| Q35108358 | Hepatitis B virus X protein downregulates expression of the miR-16 family in malignant hepatocytes in vitro |
| Q37050612 | High DRC Levels Are Associated with Let-7b Overexpression in Women with Breast Cancer |
| Q36414198 | High copy number variation of cancer-related microRNA genes and frequent amplification of DICER1 and DROSHA in lung cancer. |
| Q33842759 | High-risk myeloma is associated with global elevation of miRNAs and overexpression of EIF2C2/AGO2. |
| Q28534598 | High-throughput miRNA and mRNA sequencing of paired colorectal normal, tumor and metastasis tissues and bioinformatic modeling of miRNA-1 therapeutic applications |
| Q37337916 | Higher miRNA tolerance in immortal Li-Fraumeni fibroblasts with abrogated interferon signaling pathway |
| Q49252646 | Highly multiplexed single-cell quantitative PCR. |
| Q24338421 | Hippo signaling regulates microprocessor and links cell-density-dependent miRNA biogenesis to cancer |
| Q98611509 | Hippo/MST blocks breast cancer by downregulating WBP2 oncogene expression via miRNA processor Dicer |
| Q89481514 | Histone Citrullination Represses MicroRNA Expression, Resulting in Increased Oncogene mRNAs in Somatolactotrope Cells |
| Q36070032 | Histone Deacetylase 10 Regulates the Cell Cycle G2/M Phase Transition via a Novel Let-7-HMGA2-Cyclin A2 Pathway |
| Q58543406 | Holo-Seq: single-cell sequencing of holo-transcriptome |
| Q33869721 | Hsa-miR-196a2 Rs11614913 polymorphism contributes to cancer susceptibility: evidence from 15 case-control studies |
| Q60926135 | Human Papillomavirus 16 Oncoproteins Downregulate the Expression of miR-148a-3p, miR-190a-5p, and miR-199b-5p in Cervical Cancer |
| Q38708204 | Human and primate-specific microRNAs in cancer: Evolution, and significance in comparison with more distantly-related research models: The great potential of evolutionary young microRNA in cancer research. |
| Q35598832 | Hypoxia potentiates microRNA-mediated gene silencing through posttranslational modification of Argonaute2. |
| Q34628919 | Hypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICER. |
| Q34687371 | IMP-1 displays cross-talk with K-Ras and modulates colon cancer cell survival through the novel proapoptotic protein CYFIP2 |
| Q90307906 | INPP1 up-regulation by miR-27a contributes to the growth, migration and invasion of human cervical cancer |
| Q38909927 | IRF7 promotes glioma cell invasion by inhibiting AGO2 expression |
| Q37403837 | Identification of a pan-cancer oncogenic microRNA superfamily anchored by a central core seed motif |
| Q35151588 | Identification of miRNAs differentially expressed in clinical stages of human colorectal carcinoma-an investigation in Guangzhou, China |
| Q39475915 | Identification of microprocessor-dependent cancer cells allows screening for growth-sustaining micro-RNAs. |
| Q36276264 | Identification of plasma microRNA profiles for primary resistance to EGFR-TKIs in advanced non-small cell lung cancer (NSCLC) patients with EGFR activating mutation |
| Q33692886 | Identification of small molecule inhibitors of the Lin28-mediated blockage of pre-let-7g processing |
| Q33597265 | Identification of small molecules that suppress microRNA function and reverse tumorigenesis |
| Q34109986 | Identification of the miR-106b~25 microRNA cluster as a proto-oncogenic PTEN-targeting intron that cooperates with its host gene MCM7 in transformation |
| Q38430180 | Identifying the miRNA signature associated with survival time in patients with lung adenocarcinoma using miRNA expression profiles |
| Q91727003 | Immunological Effects of Epigenetic Modifiers |
| Q64107156 | Impacts of single nucleotide polymorphisms in three microRNAs (miR-146a, miR-196a2 and miR-499) on the susceptibility to cervical cancer among Indian women |
| Q35034871 | Impaired MicroRNA Processing Facilitates Breast Cancer Cell Invasion by Upregulating Urokinase-Type Plasminogen Activator Expression |
| Q92987363 | Impaired microRNA processing by DICER1 downregulation endows thyroid cancer with increased aggressiveness |
| Q47292103 | Impairing the microRNA biogenesis pathway induces proteome modifications characterized by size bias and enrichment in antioxidant proteins |
| Q56533161 | Importance of miRNA stability and alternative primary miRNA isoforms in gene regulation during development |
| Q52978789 | In situ quantitation of intracellular microRNA in the whole cell cycle with a functionalized carbon nanosphere probe. |
| Q33768138 | In vitro antineoplastic effects of brivaracetam and lacosamide on human glioma cells |
| Q35981890 | In vivo structure-function analysis of human Dicer reveals directional processing of precursor miRNAs |
| Q33558454 | In-depth analysis of Kaposi's sarcoma-associated herpesvirus microRNA expression provides insights into the mammalian microRNA-processing machinery |
| Q33474837 | Increased microRNA activity in human cancers |
| Q34071950 | Inhibition of breast cancer metastasis with microRNA-302a by downregulation of CXCR4 expression |
| Q39400767 | Inhibition of miR-9 de-represses HuR and DICER1 and impairs Hodgkin lymphoma tumour outgrowth in vivo |
| Q64096149 | Inhibition of miR‑214 attenuates the migration and invasion of triple‑negative breast cancer cells |
| Q43825935 | Integrated analysis of miRNA and mRNA profiles enables target acquisition in human cancers |
| Q36820041 | Integrated transcriptional and competitive endogenous RNA networks are cross-regulated in permissive molecular environments |
| Q37267032 | Integrating the MicroRNome into the study of lung disease |
| Q33670486 | Integration of mRNA expression profile, copy number alterations, and microRNA expression levels in breast cancer to improve grade definition |
| Q37216672 | Integrative genomic approaches to understanding cancer. |
| Q37574182 | Interaction-based discovery of functionally important genes in cancers |
| Q39673740 | Interleukin-23 acts as antitumor agent on childhood B-acute lymphoblastic leukemia cells |
| Q39736137 | Interleukin-27 inhibits pediatric B-acute lymphoblastic leukemia cell spreading in a preclinical model |
| Q41510831 | Interplay between miR-574-3p and hnRNP L regulates VEGFA mRNA translation and tumorigenesis |
| Q38020473 | Interrelationship between microsatellite instability and microRNA in gastrointestinal cancer. |
| Q34771731 | Involvement of microRNAs in lung cancer biology and therapy |
| Q34774009 | KIT signaling regulates MITF expression through miRNAs in normal and malignant mast cell proliferation |
| Q46061449 | KSRP promotes the maturation of a group of miRNA precursors. |
| Q24338307 | LIM-domain proteins, LIMD1, Ajuba, and WTIP are required for microRNA-mediated gene silencing |
| Q36732532 | LIN-41/TRIM71: emancipation of a miRNA target |
| Q37514333 | LIN28 is involved in glioma carcinogenesis and predicts outcomes of glioblastoma multiforme patients |
| Q50781580 | LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression. |
| Q35022313 | LIN28B polymorphisms influence susceptibility to epithelial ovarian cancer |
| Q51539368 | Labeling small RNAs through chemical ligation at the 5' terminus: enzyme-free or combined with enzymatic 3'-labeling. |
| Q24653755 | Let-7 and miR-200 microRNAs: guardians against pluripotency and cancer progression |
| Q24675225 | Let-7 expression defines two differentiation stages of cancer |
| Q33997274 | Let-7a is a direct EWS-FLI-1 target implicated in Ewing's sarcoma development |
| Q54410902 | Let-7a regulation of insulin-like growth factors in breast cancer. |
| Q33823239 | Let-7g targets collagen type I alpha2 and inhibits cell migration in hepatocellular carcinoma |
| Q45888331 | Let7a inhibits the growth of endometrial carcinoma cells by targeting Aurora-B. |
| Q24652787 | Lin-28 interaction with the Let-7 precursor loop mediates regulated microRNA processing |
| Q39546229 | Lin-28 reactivation is required for let-7 repression and proliferation in human small cell lung cancer cells |
| Q24645026 | Lin-28B transactivation is necessary for Myc-mediated let-7 repression and proliferation |
| Q58764096 | Lin28 Signaling Supports Mammalian PNS and CNS Axon Regeneration |
| Q26770347 | Lin28 and let-7 in cell metabolism and cancer |
| Q38211596 | Lin28 and let-7: ancient milestones on the road from pluripotency to neurogenesis |
| Q37377572 | Lin28 promotes transformation and is associated with advanced human malignancies |
| Q37645034 | Lin28A activates androgen receptor via regulation of c-myc and promotes malignancy of ER-/Her2+ breast cancer |
| Q91688401 | Long noncoding RNA HOTAIR is upregulated in an aggressive subgroup of gastrointestinal stromal tumors (GIST) and mediates the establishment of gene-specific DNA methylation patterns |
| Q36741276 | Loss of miRNA biogenesis induces p19Arf-p53 signaling and senescence in primary cells |
| Q33781123 | Lung cancer: a modified epigenome |
| Q37755025 | Lung microRNA: from development to disease |
| Q49072169 | Lung tumours reprogram pulmonary dendritic cell immunogenicity at the microRNA level. |
| Q51023212 | MYC and RAF: Key Effectors in Cellular Signaling and Major Drivers in Human Cancer. |
| Q36469814 | MYC is activated by USP2a-mediated modulation of microRNAs in prostate cancer |
| Q29615469 | Many roads to maturity: microRNA biogenesis pathways and their regulation |
| Q33909926 | Maternal obesity downregulates microRNA let-7g expression, a possible mechanism for enhanced adipogenesis during ovine fetal skeletal muscle development |
| Q34661270 | Maximizing mouse cancer models |
| Q53088799 | Measuring the Expression of microRNAs Regulated by Androgens. |
| Q36709368 | Mechanism of Regulatory Effect of MicroRNA-206 on Connexin 43 in Distant Metastasis of Breast Cancer |
| Q36469676 | Mechanisms underlying the formation of induced pluripotent stem cells |
| Q36125057 | Mechanistic Roles of Noncoding RNAs in Lung Cancer Biology and Their Clinical Implications |
| Q94672741 | Metastasis inhibition by BRMS1 and miR-31 replacement therapy in claudin-low cell lines |
| Q41878893 | Metastasis suppression: a role of the Dice(r). |
| Q35634563 | Metastasis-suppressor transcript destabilization through TARBP2 binding of mRNA hairpins. |
| Q36863754 | Metformin-mediated increase in DICER1 regulates microRNA expression and cellular senescence |
| Q88030471 | MiR-124 induces autophagy-related cell death in cholangiocarcinoma cells through direct targeting of the EZH2-STAT3 signaling axis |
| Q37687364 | MiR-128 reverses the gefitinib resistance of the lung cancer stem cells by inhibiting the c-met/PI3K/AKT pathway |
| Q35742436 | MiR-21 promotes intrahepatic cholangiocarcinoma proliferation and growth in vitro and in vivo by targeting PTPN14 and PTEN. |
| Q42278964 | MiR-216b inhibits cell proliferation by targeting FOXM1 in cervical cancer cells and is associated with better prognosis |
| Q42144209 | MiR-371-373 cluster acts as a tumor-suppressor-miR and promotes cell cycle arrest in unrestricted somatic stem cells |
| Q55603693 | MiRAR-miRNA Activity Reporter for Living Cells. |
| Q35644614 | MiRNA Profiles in Lymphoblastoid Cell Lines of Finnish Prostate Cancer Families |
| Q36557552 | MiRNA-10a is upregulated in NSCLC and may promote cancer by targeting PTEN |
| Q37993984 | MiRNA-34 intrinsically links p53 tumor suppressor and Wnt signaling. |
| Q37696294 | MiRNA-3978 regulates peritoneal gastric cancer metastasis by targeting legumain |
| Q33555052 | MiRNA-99a directly regulates AGO2 through translational repression in hepatocellular carcinoma |
| Q37982054 | MiRNAs and LincRNAs: Could they be considered as biomarkers in colorectal cancer? |
| Q50117508 | MiRNAs at the Crossroads between Innate Immunity and Cancer: Focus on Macrophages. |
| Q37614822 | Micro-RNA mediated regulation of proliferation, self-renewal and differentiation of mammalian stem cells |
| Q45711643 | Micro-RNA-128 (miRNA-128) down-regulation in glioblastoma targets ARP5 (ANGPTL6), Bmi-1 and E2F-3a, key regulators of brain cell proliferation |
| Q37764166 | Micro-RNAs and breast cancer |
| Q33614641 | MicroRNA 128a increases intracellular ROS level by targeting Bmi-1 and inhibits medulloblastoma cancer cell growth by promoting senescence |
| Q26797308 | MicroRNA Processing and Human Cancer |
| Q26768416 | MicroRNA aberrations: An emerging field for gallbladder cancer management |
| Q36691758 | MicroRNA and Epigenetics: Diagnostic and Therapeutic Opportunities |
| Q37295059 | MicroRNA and cancer--focus on apoptosis |
| Q53137197 | MicroRNA and cancer. |
| Q37200677 | MicroRNA and ovarian cancer |
| Q35875416 | MicroRNA biogenesis and cellular proliferation |
| Q42036775 | MicroRNA biogenesis is required for Myc-induced B-cell lymphoma development and survival |
| Q27013841 | MicroRNA biogenesis pathways in cancer |
| Q24642062 | MicroRNA biogenesis: there's more than one way to skin a cat |
| Q37706077 | MicroRNA control of signal transduction |
| Q35080416 | MicroRNA drop in the bloodstream and microRNA boost in the tumour caused by treatment with ribonuclease A leads to an attenuation of tumour malignancy |
| Q38262497 | MicroRNA dysregulation as a prognostic biomarker in colorectal cancer |
| Q37783909 | MicroRNA dysregulation in gastric cancer: a new player enters the game |
| Q27305161 | MicroRNA dysregulation in the spinal cord following traumatic injury |
| Q37215297 | MicroRNA expression in lymphoid malignancies: new hope for diagnosis and therapy? |
| Q36922250 | MicroRNA expression in lymphoma |
| Q24646090 | MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype |
| Q37802036 | MicroRNA functions in stress responses. |
| Q34868281 | MicroRNA in Cancer: The Involvement of Aberrant MicroRNA Biogenesis Regulatory Pathways |
| Q27001048 | MicroRNA in cancer: new hopes for antineoplastic chemotherapy |
| Q34256044 | MicroRNA in lung cancer |
| Q37069474 | MicroRNA involvement in brain tumors: from bench to bedside |
| Q84100507 | MicroRNA let-7a: a potential marker for selection of paclitaxel in ovarian cancer management |
| Q34221217 | MicroRNA let-7c is downregulated in prostate cancer and suppresses prostate cancer growth |
| Q35668910 | MicroRNA let-7c suppresses androgen receptor expression and activity via regulation of Myc expression in prostate cancer cells |
| Q36517482 | MicroRNA manipulation in colorectal cancer cells: from laboratory to clinical application |
| Q31080906 | MicroRNA profiling of Epstein-Barr virus-associated NK/T-cell lymphomas by deep sequencing |
| Q35178777 | MicroRNA profiling of rats with ochratoxin A nephrotoxicity |
| Q37286627 | MicroRNA reexpression as differentiation therapy in cancer |
| Q37913018 | MicroRNA regulation by RNA-binding proteins and its implications for cancer |
| Q37924177 | MicroRNA replacement therapy for cancer |
| Q34185623 | MicroRNA sequence and expression analysis in breast tumors by deep sequencing |
| Q24648543 | MicroRNA targets in immune genes and the Dicer/Argonaute and ARE machinery components |
| Q35596544 | MicroRNA-103-1 selectively downregulates brain NCX1 and its inhibition by anti-miRNA ameliorates stroke damage and neurological deficits |
| Q37645010 | MicroRNA-126 inhibits colon cancer cell proliferation and invasion by targeting the chemokine (C-X-C motif) receptor 4 and Ras homolog gene family, member A, signaling pathway |
| Q35965859 | MicroRNA-128-2 targets the transcriptional repressor E2F5 enhancing mutant p53 gain of function |
| Q53179822 | MicroRNA-128-3p-mediated depletion of Drosha promotes lung cancer cell migration. |
| Q42831915 | MicroRNA-139-5p Suppresses 3T3-L1 Preadipocyte Differentiation Through Notch and IRS1/PI3K/Akt Insulin Signaling Pathways. |
| Q38926588 | MicroRNA-139-5p regulates C2C12 cell myogenesis through blocking Wnt/β-catenin signaling pathway. |
| Q34294469 | MicroRNA-140 acts as a liver tumor suppressor by controlling NF-κB activity by directly targeting DNA methyltransferase 1 (Dnmt1) expression. |
| Q38720709 | MicroRNA-140 mediates RB tumor suppressor function to control stem cell-like activity through interleukin-6 |
| Q34222203 | MicroRNA-141 represses HBV replication by targeting PPARA. |
| Q39152457 | MicroRNA-148a suppresses epithelial-to-mesenchymal transition by targeting ROCK1 in non-small cell lung cancer cells |
| Q38741262 | MicroRNA-153 inhibits tumor progression in esophageal squamous cell carcinoma by targeting SNAI1. |
| Q51593946 | MicroRNA-15a inhibits the growth and invasiveness of malignant melanoma and directly targets on CDCA4 gene. |
| Q49569633 | MicroRNA-182 targets protein phosphatase 1 regulatory inhibitor subunit 1C in glioblastoma. |
| Q24654039 | MicroRNA-184 antagonizes microRNA-205 to maintain SHIP2 levels in epithelia |
| Q90576975 | MicroRNA-19a-3p regulates cell growth through modulation of the PIK3IP1-AKT pathway in hepatocellular carcinoma |
| Q35952936 | MicroRNA-203 represses selection and expansion of oncogenic Hras transformed tumor initiating cells |
| Q42264081 | MicroRNA-21 could be a molecular marker to predict the recurrence of nonmuscle invasive bladder cancer. |
| Q38720163 | MicroRNA-214 inhibits the osteogenic differentiation of human osteoblasts through the direct regulation of baculoviral IAP repeat-containing 7. |
| Q40499327 | MicroRNA-216b is Down-Regulated in Human Gastric Adenocarcinoma and Inhibits Proliferation and Cell Cycle Progression by Targeting Oncogene HDAC8. |
| Q43693182 | MicroRNA-22 expression in hepatocellular carcinoma and its correlation with ezrin protein |
| Q83603613 | MicroRNA-221 regulates FAS-induced fulminant liver failure |
| Q55711744 | MicroRNA-23a/27a/24-2 cluster promotes gastric cancer cell proliferation synergistically. |
| Q34733320 | MicroRNA-25 regulates small cell lung cancer cell development and cell cycle through cyclin E2 |
| Q28280193 | MicroRNA-26a is strongly downregulated in melanoma and induces cell death through repression of silencer of death domains (SODD) |
| Q36673955 | MicroRNA-302 replacement therapy sensitizes breast cancer cells to ionizing radiation |
| Q35617323 | MicroRNA-302a Suppresses Tumor Cell Proliferation by Inhibiting AKT in Prostate Cancer. |
| Q33684869 | MicroRNA-335 and its target Rock1 synergistically influence tumor progression and prognosis in osteosarcoma |
| Q55295074 | MicroRNA-411 Downregulation Enhances Tumor Growth by Upregulating MLLT11 Expression in Human Bladder Cancer. |
| Q92680791 | MicroRNA-4417 is a tumor suppressor and prognostic biomarker for triple-negative breast cancer |
| Q38743265 | MicroRNA-490 regulates lung cancer metastasis by targeting poly r(C)-binding protein 1. |
| Q36413411 | MicroRNA-494 inhibits cell proliferation and invasion of chondrosarcoma cells in vivo and in vitro by directly targeting SOX9. |
| Q35009884 | MicroRNA-500 as a potential diagnostic marker for hepatocellular carcinoma. |
| Q39333737 | MicroRNA-590-5p regulates proliferation and invasion in human hepatocellular carcinoma cells by targeting TGF-β RII. |
| Q92750759 | MicroRNA-639 is Down-Regulated in Hepatocellular Carcinoma Tumor Tissue and Inhibits Proliferation and Migration of Human Hepatocellular Carcinoma Cells Through the KAT7/Wnt/β-Catenin Pathway |
| Q34169033 | MicroRNA-645, up-regulated in human adencarcinoma of gastric esophageal junction, inhibits apoptosis by targeting tumor suppressor IFIT2. |
| Q36243947 | MicroRNA-7 enhances cytotoxicity induced by gefitinib in non-small cell lung cancer via inhibiting the EGFR and IGF1R signalling pathways |
| Q36215852 | MicroRNA-9 inhibition of cell proliferation and identification of novel miR-9 targets by transcriptome profiling in breast cancer cells |
| Q42328130 | MicroRNA-98 regulates osteogenic differentiation of human bone mesenchymal stromal cells by targeting BMP2. |
| Q64922991 | MicroRNA-Mediated Health-Promoting Effects of Phytochemicals. |
| Q36980007 | MicroRNA-mediated control of macrophages and its implications for cancer |
| Q41911349 | MicroRNA-mediated gene silencing modulates the UV-induced DNA-damage response |
| Q26829175 | MicroRNA-mediated regulation of differentiation and trans-differentiation in stem cells |
| Q37135817 | MicroRNA: An emerging therapeutic target and intervention tool |
| Q42004179 | MicroRNA: Biogenesis, Function and Role in Cancer |
| Q36294667 | MicroRNA: implications for cancer |
| Q33786861 | MicroRNA: important player in the pathobiology of multiple myeloma |
| Q34814749 | MicroRNAome profiling in benign and malignant neurofibromatosis type 1-associated nerve sheath tumors: evidences of PTEN pathway alterations in early NF1 tumorigenesis |
| Q34158964 | MicroRNAs As Biomarkers For Clinical Features Of Lung Cancer |
| Q57106460 | MicroRNAs and DNA-Damaging Drugs in Breast Cancer: Strength in Numbers |
| Q37288070 | MicroRNAs and PIWI-interacting RNAs in oncology |
| Q41906288 | MicroRNAs and cancer: short RNAs go a long way. |
| Q38184973 | MicroRNAs and human diseases: diagnostic and therapeutic potential |
| Q34696427 | MicroRNAs and their applications in kidney diseases |
| Q37722649 | MicroRNAs and their role in gynecological tumors |
| Q21195211 | MicroRNAs and their target gene networks in breast cancer |
| Q94046968 | MicroRNAs as Key Regulators of Ovarian Cancers |
| Q41974673 | MicroRNAs as Molecular Targets for Cancer Therapy: On the Modulation of MicroRNA Expression. |
| Q34162262 | MicroRNAs as biomarkers in colorectal cancer |
| Q37114804 | MicroRNAs as modulators of smoking-induced gene expression changes in human airway epithelium |
| Q35015730 | MicroRNAs as potential cancer therapeutics. |
| Q37032639 | MicroRNAs as targets for antisense-based therapeutics |
| Q37855085 | MicroRNAs as therapeutic targets in cancer |
| Q80220517 | MicroRNAs as tumor suppressors |
| Q38933683 | MicroRNAs in Control of Stem Cells in Normal and Malignant Hematopoiesis |
| Q41660637 | MicroRNAs in Different Histologies of Soft Tissue Sarcoma: A Comprehensive Review |
| Q35819878 | MicroRNAs in Neural Stem Cells and Neurogenesis |
| Q30437444 | MicroRNAs in cancer |
| Q38212798 | MicroRNAs in cervical cancer: evidences for a miRNA profile deregulated by HPV and its impact on radio-resistance. |
| Q37431350 | MicroRNAs in cholangiociliopathies |
| Q37821149 | MicroRNAs in embryonic stem cell function and fate |
| Q34325959 | MicroRNAs in human cancer |
| Q35552809 | MicroRNAs in mutagenesis, genomic instability, and DNA repair |
| Q92144036 | MicroRNAs in non-small cell lung cancer: Gene regulation, impact on cancer cellular processes, and therapeutic potential |
| Q33796565 | MicroRNAs in ovarian carcinomas |
| Q26823456 | MicroRNAs in respiratory disease. A clinician's overview |
| Q37297730 | MicroRNAs in the pathogenesis of Lung Cancer |
| Q36032709 | MicroRNAs link estrogen receptor alpha status and Dicer levels in breast cancer |
| Q26777313 | MicroRNAs, TGF-β signaling, and the inflammatory microenvironment in cancer |
| Q34348967 | MicroRNAs, cancer and cancer stem cells |
| Q35388050 | MicroRNAs, diet, and cancer: new mechanistic insights on the epigenetic actions of phytochemicals |
| Q37679619 | MicroRNAs-role in lung cancer |
| Q38765883 | MicroRNAs: Biomarkers, Diagnostics, and Therapeutics |
| Q37970478 | MicroRNAs: critical regulators of epithelial to mesenchymal (EMT) and mesenchymal to epithelial transition (MET) in cancer progression |
| Q28657834 | MicroRNAs: history, biogenesis, and their evolving role in animal development and disease |
| Q37287182 | MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death |
| Q35673637 | MicroRNAs: short non-coding players in cancer chemoresistance. |
| Q33395144 | Microarray-based approach identifies microRNAs and their target functional patterns in polycystic kidney disease |
| Q38363519 | Microsatellite instability: an update |
| Q36853421 | Mir-375 enhances ruthenium-derived compound Rawq01 induced cell death in human ovarian cancer |
| Q33878956 | Modeling bias and variation in the stochastic processes of small RNA sequencing. |
| Q28478852 | Modeling of miRNA and drug action in the EGFR signaling pathway |
| Q38166839 | Modulation of epigenetic regulators and cell fate decisions by miRNAs |
| Q29620776 | Modulation of microRNA processing by p53 |
| Q42792442 | Molecular and cellular pathways associated with chromosome 1p deletions during colon carcinogenesis |
| Q46277416 | Molecular genetics and cellular events of K-Ras-driven tumorigenesis. |
| Q26824599 | Molecular testing in lung cancer in the era of precision medicine |
| Q41455736 | Monoallelic but not biallelic loss of Dicer1 promotes tumorigenesis in vivo |
| Q39934018 | Multiple regression analysis of mRNA-miRNA associations in colorectal cancer pathway. |
| Q36997841 | Multiplexed detection methods for profiling microRNA expression in biological samples |
| Q27001000 | Multistep model of cervical cancer: participation of miRNAs and coding genes |
| Q34077879 | Mutagen-specific mutation signature determines global microRNA binding |
| Q55026448 | Mutant p53 inhibits miRNA biogenesis by interfering with the microprocessor complex. |
| Q27316256 | Mutations in conserved residues of the C. elegans microRNA Argonaute ALG-1 identify separable functions in ALG-1 miRISC loading and target repression |
| Q36691039 | Mutual antagonism between hepatitis B viral mRNA and host microRNA let-7. |
| Q39069897 | Mutual regulation of microRNAs and DNA methylation in human cancers |
| Q39565441 | Myc-mediated repression of microRNA-34a promotes high-grade transformation of B-cell lymphoma by dysregulation of FoxP1 |
| Q37794795 | Myc: Maestro of MicroRNAs |
| Q36090989 | NF-κB-DICER-miRs Axis Regulates TNF-α Expression in Responses to Endotoxin Stress |
| Q55355075 | NF2/Merlin Inactivation and Potential Therapeutic Targets in Mesothelioma. |
| Q36738876 | Negative correlation of ITCH E3 ubiquitin ligase and miRNA-106b dictates metastatic progression in pancreatic cancer |
| Q55344929 | Neuronal activity regulates DROSHA via autophagy in spinal muscular atrophy. |
| Q38309155 | New insights into lung development and diseases: the role of microRNAs. |
| Q35854108 | Next generation sequencing for profiling expression of miRNAs: technical progress and applications in drug development |
| Q37686557 | No association between single nucleotide polymorphisms in pre-mirnas and the risk of gastric cancer in Chinese population |
| Q38667224 | Non-coding RNA in Ovarian Development and Disease. |
| Q36439924 | Non-coding RNAs in DNA damage response |
| Q37955474 | Non-coding RNAs in cancer initiation and progression and as novel biomarkers |
| Q29618039 | Non-coding RNAs in human disease |
| Q38244618 | Noncoding RNA response to xenobiotic exposure: an indicator of toxicity and carcinogenicity |
| Q47663573 | Noncoding RNA-related polymorphisms in pediatric acute lymphoblastic leukemia susceptibility. |
| Q26864697 | Noncoding RNAs in DNA repair and genome integrity |
| Q34898535 | Notch signaling in the malignant bone marrow microenvironment: implications for a niche-based model of oncogenesis |
| Q37146759 | Novel DICER1 mutation as cause of multinodular goiter in children |
| Q35017844 | Novel small RNA expression libraries uncover hsa-miR-30b and hsa-miR-30c as important factors in anoikis resistance |
| Q35345655 | Nuclear receptor liver receptor homologue 1 (LRH-1) regulates pancreatic cancer cell growth and proliferation |
| Q27334649 | Oligo- and polymetastatic progression in lung metastasis(es) patients is associated with specific microRNAs |
| Q42933989 | Oncogene-dependent control of miRNA biogenesis and metastatic progression in a model of undifferentiated pleomorphic sarcoma |
| Q37812094 | Oncogenic microRNAs (OncomiRs) as a new class of cancer biomarkers |
| Q41583993 | Opposing microRNA families regulate self-renewal in mouse embryonic stem cells |
| Q47811340 | Overexpressed miR-128a enhances chemoradiotherapy to laryngeal cancer cells and its correlation with BMI1. |
| Q33723876 | Overexpression of miR-155 in clear-cell renal cell carcinoma and its oncogenic effect through targeting FOXO3a |
| Q35909674 | Overexpression of the RNA-binding proteins Lin28B and IGF2BP3 (IMP3) is associated with chemoresistance and poor disease outcome in ovarian cancer |
| Q38163463 | Overview of various techniques/platforms with critical evaluation of each |
| Q36375834 | PDGF-B-mediated downregulation of miR-21: new insights into PDGF signaling in glioblastoma |
| Q41126547 | PFKL/miR-128 axis regulates glycolysis by inhibiting AKT phosphorylation and predicts poor survival in lung cancer |
| Q39480671 | PI3K/AKT signaling determines a dynamic switch between distinct KSRP functions favoring skeletal myogenesis |
| Q30583504 | PROGmiR: a tool for identifying prognostic miRNA biomarkers in multiple cancers using publicly available data |
| Q34097621 | PTEN modulates miR-21 processing via RNA-regulatory protein RNH1. |
| Q39129655 | Phospho-ΔNp63α-dependent microRNAs modulate chemoresistance of squamous cell carcinoma cells to cisplatin: at the crossroads of cell life and death |
| Q38663683 | Phospho-ΔNp63α/microRNA network modulates epigenetic regulatory enzymes in squamous cell carcinomas |
| Q37228032 | Poly r(C) binding protein (PCBP) 1 is a negative regulator of thyroid carcinoma |
| Q47284891 | Poly r(C) binding protein 1-mediated regulation of microRNA expression underlies post-sevoflurane amelioration of acute lung injury in rats |
| Q51506668 | Poly r(C) binding protein is post-transcriptionally repressed by MiR-490-3p to potentiate squamous cell carcinoma. |
| Q64926353 | Polymorphism of miRNA and esophageal cancer risk: an updated systemic review and meta-analysis. |
| Q34459038 | Polymorphisms in MicroRNAs are associated with survival in non-small cell lung cancer |
| Q47438993 | Polymorphisms in miRNA processing genes and their role in osteosarcoma risk. |
| Q36504138 | Polymorphisms in pre-miRNA genes and cooking oil fume exposure as well as their interaction on the risk of lung cancer in a Chinese nonsmoking female population |
| Q43123531 | Post-transcriptional control of DGCR8 expression by the Microprocessor |
| Q58548774 | Post-transcriptional control of miRNA biogenesis |
| Q38784282 | Post-transcriptional regulation of gene expression in neural stem cells |
| Q38359188 | Posttranscriptional regulation of miRNAs harboring conserved terminal loops. |
| Q35667581 | Posttranscriptional regulation of miRNAs in the DNA damage response |
| Q37705222 | Potential role of micro-RNAs in head and neck tumorigenesis. |
| Q42282855 | Potentially functional genetic variants in microRNA processing genes and risk of HBV-related hepatocellular carcinoma. |
| Q37695446 | Prediction of therapeutic microRNA based on the human metabolic network |
| Q42822627 | Prioritization of candidate cancer genes--an aid to oncogenomic studies |
| Q34086636 | Prognostic biomarkers in ovarian cancer |
| Q43978326 | Prognostic role of microRNA polymorphisms in advanced gastric cancer: a translational study of the Arbeitsgemeinschaft Internistische Onkologie (AIO). |
| Q28393448 | Prognostic significance of deregulated dicer expression in breast cancer |
| Q37330716 | Prognostic value of Dicer expression in human breast cancers and association with the mesenchymal phenotype. |
| Q24653978 | Proliferating cells express mRNAs with shortened 3' untranslated regions and fewer microRNA target sites |
| Q36065663 | Proliferation and tumorigenesis of a murine sarcoma cell line in the absence of DICER1. |
| Q35871679 | RETRACTED: A TARBP2 mutation in human cancer impairs microRNA processing and DICER1 function |
| Q36879784 | RISCy business: MicroRNAs, pathogenesis, and viruses |
| Q38656079 | RNA-Binding Proteins in Cancer: Old Players and New Actors. |
| Q33966769 | RNA-ligase-dependent biases in miRNA representation in deep-sequenced small RNA cDNA libraries |
| Q36002513 | ROCK inhibition enhances microRNA function by promoting deadenylation of targeted mRNAs via increasing PAIP2 expression |
| Q39365472 | Rare Drosha splice variants are deficient in microRNA processing but do not affect general microRNA expression in cancer cells |
| Q37604836 | Recent insights into the pathogenesis of colorectal cancer. |
| Q34026072 | Receptor for activated protein kinase C: requirement for efficient microRNA function and reduced expression in hepatocellular carcinoma. |
| Q36709112 | Recurrent DGCR8, DROSHA, and SIX homeodomain mutations in favorable histology Wilms tumors. |
| Q33772549 | Recurrent somatic mutation in DROSHA induces microRNA profile changes in Wilms tumour |
| Q41459548 | Reduced expression of mir15a in the blood of patients with oral squamous cell carcinoma is associated with tumor staging |
| Q28569289 | Reduction of Dicer impairs Schwann cell differentiation and myelination |
| Q39262216 | Regulating distal tip cell migration in space and time |
| Q28382842 | Regulating the Regulators: microRNA and Asthma |
| Q35575239 | Regulation of MicroRNA Biogenesis: A miRiad of mechanisms |
| Q36022673 | Regulation of MicroRNAs, and the Correlations of MicroRNAs and Their Targeted Genes by Zinc Oxide Nanoparticles in Ovarian Granulosa Cells. |
| Q42626406 | Regulation of autophagy, NF-κB signaling, and cell viability by miR-124 in KRAS mutant mesenchymal-like NSCLC cells. |
| Q38095509 | Regulation of miRNA biogenesis and turnover in the immune system. |
| Q37110886 | Regulation of microRNA processing in development, differentiation and cancer |
| Q34573664 | Regulation of microRNA-mediated gene silencing by microRNA precursors. |
| Q38191102 | Regulation of microRNAs in cancer metastasis. |
| Q38937494 | Regulation of the microRNA processor DGCR8 by hepatitis B virus proteins via the transcription factor YY1. |
| Q37715822 | Regulation of tumor suppressor p53 at the RNA level |
| Q39917799 | Repression of Dicer is associated with invasive phenotype and chemoresistance in ovarian cancer |
| Q96128249 | Rescuing Dicer expression in inflamed colon tissues alleviates colitis and prevents colitis-associated tumorigenesis |
| Q35002243 | Rescuing dicer defects via inhibition of an anti-dicing nuclease. |
| Q35411058 | Restoration of miR17/20a in solid tumor cells enhances the natural killer cell antitumor activity by targeting Mekk2. |
| Q34126469 | Resveratrol modulates the levels of microRNAs targeting genes encoding tumor-suppressors and effectors of TGFβ signaling pathway in SW480 cells |
| Q31103041 | Retracted: MiR-145 Regulates Epithelial to Mesenchymal Transition of Breast Cancer Cells by Targeting Oct4 |
| Q34776791 | Retracted: MicroRNA-302a Functions as a Putative Tumor Suppressor in Colon Cancer by Targeting Akt |
| Q34824379 | Reversal and prevention of arsenic-induced human bronchial epithelial cell malignant transformation by microRNA-200b. |
| Q34208062 | Reversible block of mouse neural stem cell differentiation in the absence of dicer and microRNAs. |
| Q27000282 | Role of Exosomal Noncoding RNAs in Lung Carcinogenesis |
| Q37961734 | Role of epigenomics in ovarian and endometrial cancers |
| Q39414649 | Role of microRNAs 99b, 181a, and 181b in the differentiation of human embryonic stem cells to vascular endothelial cells |
| Q26770485 | Role of microRNAs in chemoresistance |
| Q47984355 | Role of phytochemicals in the modulation of miRNA expression in cancer |
| Q39621434 | Role of ribosomal protein RPS2 in controlling let-7a expression in human prostate cancer |
| Q35955737 | Roles for microRNAs in conferring robustness to biological processes |
| Q37012057 | Roles of microRNAs and their targets in cancer |
| Q90740776 | Roles of microRNAs as non-invasive biomarker and therapeutic target in colorectal cancer |
| Q38086009 | Roles of microRNAs during prostatic tumorigenesis and tumor progression |
| Q37759650 | Roles of small RNAs in tumor formation |
| Q26829794 | SNPing cancer in the bud: microRNA and microRNA-target site polymorphisms as diagnostic and prognostic biomarkers in cancer |
| Q42375179 | SUMO1 modification of KHSRP regulates tumorigenesis by preventing the TL-G-Rich miRNA biogenesis |
| Q37416031 | Selective blockade of DCAMKL-1 results in tumor growth arrest by a Let-7a MicroRNA-dependent mechanism |
| Q24609864 | Selective blockade of microRNA processing by Lin28 |
| Q64271381 | Sevoflurane exerts protective effects on liver ischemia/reperfusion injury by regulating expression via miR-9-5p |
| Q35070602 | Shielding the messenger (RNA): microRNA-based anticancer therapies |
| Q37288961 | Signaling by p38 MAPK stimulates nuclear localization of the microprocessor component p68 for processing of selected primary microRNAs |
| Q35960434 | Significant association between functional microRNA polymorphisms and head and neck cancer susceptibility: a comprehensive meta-analysis |
| Q35907694 | Sin3a is essential for the genome integrity and viability of pluripotent cells |
| Q37115608 | Single nucleotide polymorphisms of microRNA machinery genes modify the risk of renal cell carcinoma. |
| Q33579702 | Single-nucleotide polymorphisms among microRNA: big effects on cancer |
| Q36897977 | Slug-upregulated miR-221 promotes breast cancer progression through suppressing E-cadherin expression |
| Q37448284 | Small RNA: a large contributor to carcinogenesis? |
| Q36608200 | Small and Long Non-Coding RNAs: Novel Targets in Perspective Cancer Therapy. |
| Q33835075 | Small molecule enoxacin is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2-mediated microRNA processing |
| Q36567511 | Small molecules targeting microRNA for cancer therapy: Promises and obstacles |
| Q34425882 | Small players with big roles: microRNAs as targets to inhibit breast cancer progression |
| Q35762628 | Smg6/Est1 licenses embryonic stem cell differentiation via nonsense-mediated mRNA decay |
| Q43586010 | Somatic mutations and losses of expression of microRNA regulation-related genes AGO2 and TNRC6A in gastric and colorectal cancers |
| Q37906461 | Stem cell microRNAs in senescence and immortalization: novel players in cancer therapy |
| Q36164105 | Stop the dicing in hematopoiesis: what have we learned? |
| Q39440775 | Stress-induced changes in miRNA biogenesis and functioning |
| Q27661993 | Structure of the dimerization domain of DiGeorge Critical Region 8 |
| Q24651985 | Suppression of non-small cell lung tumor development by the let-7 microRNA family |
| Q54295411 | Suppression of the let-7b microRNA pathway by DNA hypermethylation in infant acute lymphoblastic leukemia with MLL gene rearrangements. |
| Q90399991 | Surveillance of Tumour Development: The Relationship Between Tumour-Associated RNAs and Ribonucleases |
| Q38302933 | Synthesis of fluorescent dye-doped silica nanoparticles for target-cell-specific delivery and intracellular microRNA imaging. |
| Q47302451 | Synthetic lethality between Rb, p53 and Dicer or miR-17-92 in retinal progenitors suppresses retinoblastoma formation |
| Q37888763 | Systematic exploration of cancer-associated microRNA through functional screening assays |
| Q28391909 | Systems biology of cancer: entropy, disorder, and selection-driven evolution to independence, invasion and "swarm intelligence" |
| Q34662448 | TAp63 suppresses metastasis through coordinate regulation of Dicer and miRNAs |
| Q39153280 | TGF-β1 suppression of microRNA-450b-5p expression: a novel mechanism for blocking myogenic differentiation of rhabdomyosarcoma |
| Q39155781 | TRAIL-induced miR-146a expression suppresses CXCR4-mediated human breast cancer migration |
| Q51254914 | Tamoxifen differentially regulates miR-29b-1 and miR-29a expression depending on endocrine-sensitivity in breast cancer cells. |
| Q39369810 | Target-cell-specific delivery, imaging, and detection of intracellular microRNA with a multifunctional SnO2 nanoprobe |
| Q24645192 | Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters |
| Q42269889 | Targeting MYC-Regulated miRNAs to Combat Cancer |
| Q41778989 | Targeting MicroRNA in Cancer Using Plant-Based Proanthocyanidins |
| Q37628264 | Targeting MicroRNAs in Cancer Gene Therapy |
| Q37778399 | Targeting miRNAs in osteoblast differentiation and bone formation |
| Q38997351 | Targeting mutant p53 in cancer: a long road to precision therapy. |
| Q37700158 | Targeting of mRNAs by multiple miRNAs: the next step |
| Q33779176 | Targetome profiling and functional genetics implicate miR-618 in lymphomagenesis |
| Q41894251 | Targetome profiling, pathway analysis and genetic association study implicate miR-202 in lymphomagenesis |
| Q88357678 | The E3 ligase for metastasis associated 1 protein, TRIM25, is targeted by microRNA-873 in hepatocellular carcinoma |
| Q37478615 | The FEN1 L209P mutation interferes with long-patch base excision repair and induces cellular transformation |
| Q40795590 | The Impact of MicroRNAs on Brain Aging and Neurodegeneration |
| Q28389364 | The NF90-NF45 complex functions as a negative regulator in the microRNA processing pathway |
| Q58694197 | The Network of Non-coding RNAs in Cancer Drug Resistance |
| Q34134295 | The Promise of MicroRNA Replacement Therapy |
| Q26765181 | The RNA helicase A in malignant transformation |
| Q37401219 | The RNA-binding protein KSRP promotes the biogenesis of a subset of microRNAs |
| Q52880165 | The Role of Dysregulated MicroRNA Expression in Lung Cancer. |
| Q26748969 | The Three Paralogous MicroRNA Clusters in Development and Disease, miR-17-92, miR-106a-363, and miR-106b-25 |
| Q27012447 | The Tumor Cytosol miRNAs, Fluid miRNAs, and Exosome miRNAs in Lung Cancer |
| Q85798687 | The association between common genetic variant of microRNA-499 and cancer susceptibility: a meta-analysis |
| Q39248311 | The association between miR-423 rs6505162 polymorphism and cancer susceptibility: a systematic review and meta-analysis |
| Q35060824 | The association between two microRNA variants (miR-499, miR-149) and gastrointestinal cancer risk: a meta-analysis |
| Q34988157 | The associations of single nucleotide polymorphisms in miR-146a, miR-196a and miR-499 with breast cancer susceptibility |
| Q37987661 | The biology of personalized cancer medicine: facing individual complexities underlying hallmark capabilities |
| Q90022490 | The correlation of circulating pro-angiogenic miRNAs' expressions with disease risk, clinicopathological features, and survival profiles in gastric cancer |
| Q48146055 | The effects of Curcumin on HCT-116 cells proliferation and apoptosis via the miR-491/PEG10 pathway. |
| Q34933986 | The emerging role of miR-200 family of microRNAs in epithelial-mesenchymal transition and cancer metastasis |
| Q36035567 | The emerging roles of YAP and TAZ in cancer |
| Q40416435 | The epigenetic regulation of Dicer and microRNA biogenesis by Panobinostat |
| Q28082775 | The hematopoietic stem cell niche in homeostasis and disease |
| Q37415431 | The impact of microRNAs on colorectal cancer |
| Q91563098 | The inhibitory function of icariin in cell model of benign prostatic hyperplasia by upregulation of miR-7 |
| Q37695727 | The let-7/LIN-41 pathway regulates reprogramming to human induced pluripotent stem cells by controlling expression of prodifferentiation genes |
| Q37344777 | The locus of microRNA-10b: a critical target for breast cancer insurgence and dissemination |
| Q37385514 | The mammalian ovary from genesis to revelation |
| Q35402507 | The microRNA-520a-3p inhibits proliferation, apoptosis and metastasis by targeting MAP3K2 in non-small cell lung cancer |
| Q39467143 | The microRNA-processing enzymes: Drosha and Dicer can predict prognosis of nasopharyngeal carcinoma |
| Q36432986 | The microcosmos of cancer |
| Q37565233 | The modulation of Dicer regulates tumor immunogenicity in melanoma |
| Q37286651 | The muscle-specific microRNA miR-206 blocks human rhabdomyosarcoma growth in xenotransplanted mice by promoting myogenic differentiation |
| Q33754114 | The new concepts on overcoming drug resistance in lung cancer |
| Q95486222 | The origins and functions of hepatic polyploidy |
| Q38261312 | The p53/microRNA connection in gastrointestinal cancer |
| Q41907351 | The paradox of dicer in cancer |
| Q38848413 | The pharmacogenomics of osteosarcoma |
| Q37766501 | The realm of microRNAs in cancers |
| Q54267169 | The regulatory mechanism of CCR7 gene expression and its involvement in the metastasis and progression of gastric cancer. |
| Q35656801 | The ribonuclease DIS3 promotes let-7 miRNA maturation by degrading the pluripotency factor LIN28B mRNA. |
| Q24632764 | The role of dicer in DNA damage repair |
| Q38221290 | The role of miRNAs in cancer: from pathogenesis to therapeutic implications |
| Q64994278 | The role of miRNAs in cholangiocarcinoma. |
| Q38600963 | The role of miRNAs in endometrial cancer |
| Q36396579 | The role of microRNAs in breast cancer migration, invasion and metastasis |
| Q37901391 | The roles of microRNAs in tumorigenesis and angiogenesis. |
| Q37331689 | The short and the long of UTRs |
| Q36457427 | The significance of epigenetic alterations in lung carcinogenesis |
| Q39253721 | The stem cell E3-ligase Lin-41 promotes liver cancer progression through inhibition of microRNA-mediated gene silencing |
| Q38981547 | The synergistic regulation of VEGF-mediated angiogenesis through miR-190 and target genes |
| Q37946457 | The three M's: melanoma, microphthalmia-associated transcription factor and microRNA. |
| Q36475073 | The tiny world of microRNAs in the cross hairs of the mammalian eye. |
| Q24655262 | Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model |
| Q24651333 | Therapeutic microRNA strategies in human cancer |
| Q50532322 | Toxicity study of ochratoxin A using HEK293 and HepG2 cell lines based on microRNA profiling. |
| Q42927483 | Transcription and processing: multilayer controls of RNA biogenesis by the Hippo pathway |
| Q26849961 | Transcriptional regulation of tenascin genes |
| Q37378081 | Transcriptome and small RNA deep sequencing reveals deregulation of miRNA biogenesis in human glioma |
| Q42786047 | Tumor Protein p63/microRNA Network in Epithelial Cancer Cells |
| Q34539766 | Tumor suppressor p53 meets microRNAs |
| Q36909728 | Tumor suppressor p53 plays a key role in induction of both tristetraprolin and let-7 in human cancer cells |
| Q35794801 | Tumor tissue microRNA expression in association with triple-negative breast cancer outcomes |
| Q51931778 | Tumors line up for a letdown. |
| Q35917441 | Type 1 Insulin-Like Growth Factor Receptor/Insulin Receptor Substrate 1 Signaling Confers Pathogenic Activity on Breast Tumor Cells Lacking REST. |
| Q34983857 | Unique haploinsufficient role of the microRNA-processing molecule Dicer1 in a murine colitis-associated tumorigenesis model. |
| Q37649332 | Up-regulation of CRKL by microRNA-335 methylation is associated with poor prognosis in gastric cancer |
| Q35741699 | Up-regulation of matrix metalloproteinases in a mouse model of chemically induced colitis-associated cancer: the role of microRNAs |
| Q48945618 | Up-regulation of micro-RNA-221 (miRNA-221; chr Xp11.3) and caspase-3 accompanies down-regulation of the survivin-1 homolog BIRC1 (NAIP) in glioblastoma multiforme (GBM). |
| Q34190564 | Up-regulation of microRNAs in brain of human alcoholics |
| Q37718273 | Up-regulation of ribosome biogenesis by MIR196A2 genetic variation promotes endometriosis development and progression |
| Q34722597 | Upregulation of miR-150* and miR-630 induces apoptosis in pancreatic cancer cells by targeting IGF-1R. |
| Q35591421 | Use of miRNA response sequences to block off-target replication and increase the safety of an unattenuated, glioblastoma-targeted oncolytic HSV |
| Q28083010 | Utility of microRNAs and siRNAs in cervical carcinogenesis |
| Q37648073 | Validation of microRNA pathway polymorphisms in esophageal adenocarcinoma survival |
| Q38297946 | Widespread deregulation of microRNA expression in human prostate cancer. |
| Q24647067 | Widespread microRNA repression by Myc contributes to tumorigenesis |
| Q90388631 | ZFP281 Recruits MYC to Active Promoters in Regulating Transcriptional Initiation and Elongation |
| Q55428910 | [MiR-614 inhibited lung cancer cell invasion and proliferation via targeting PSA]. |
| Q89206172 | c-Myc is a novel Leishmania virulence factor by proxy that targets the host miRNA system and is essential for survival in human macrophages |
| Q85198781 | c-Myc-mediated epigenetic silencing of MicroRNA-101 contributes to dysregulation of multiple pathways in hepatocellular carcinoma |
| Q24644238 | let-7 Overexpression leads to an increased fraction of cells in G2/M, direct down-regulation of Cdc34, and stabilization of Wee1 kinase in primary fibroblasts |
| Q28290736 | let-7 regulates Dicer expression and constitutes a negative feedback loop |
| Q37402624 | mRNA expression profiles show differential regulatory effects of microRNAs between estrogen receptor-positive and estrogen receptor-negative breast cancer |
| Q36389324 | miR-10b*, a master inhibitor of the cell cycle, is down-regulated in human breast tumours. |
| Q47786478 | miR-122 promotes metastasis of clear-cell renal cell carcinoma by downregulating Dicer |
| Q21245271 | miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells |
| Q33685173 | miR-125b-2 is a potential oncomiR on human chromosome 21 in megakaryoblastic leukemia |
| Q38742653 | miR-1298 Inhibits Mutant KRAS-Driven Tumor Growth by Repressing FAK and LAMB3 |
| Q39197814 | miR-130b is an EMT-related microRNA that targets DICER1 for aggression in endometrial cancer |
| Q39271721 | miR-134 inhibits epithelial to mesenchymal transition by targeting FOXM1 in non-small cell lung cancer cells |
| Q50926666 | miR-150 promotes the proliferation of lung cancer cells by targeting P53. |
| Q28247489 | miR-15a and miR-16-1 in cancer: discovery, function and future perspectives |
| Q39291031 | miR-183 inhibits the metastasis of osteosarcoma via downregulation of the expression of Ezrin in F5M2 cells |
| Q38320511 | miR-18a promotes malignant progression by impairing microRNA biogenesis in nasopharyngeal carcinoma |
| Q89574008 | miR-196b target screen reveals mechanisms maintaining leukemia stemness with therapeutic potential |
| Q36375224 | miR-204 inhibits invasion and epithelial-mesenchymal transition by targeting FOXM1 in esophageal cancer |
| Q24613084 | miR-21 and miR-31 converge on TIAM1 to regulate migration and invasion of colon carcinoma cells |
| Q24646374 | miR-221 overexpression contributes to liver tumorigenesis |
| Q34832407 | miR-223 regulates migration and invasion by targeting Artemin in human esophageal carcinoma |
| Q36917611 | miR-26a enhances miRNA biogenesis by targeting Lin28B and Zcchc11 to suppress tumor growth and metastasis. |
| Q64963092 | miR-30 disrupts senescence and promotes cancer by targeting both p16INK4A and DNA damage pathways. |
| Q36702568 | miR-32 inhibits proliferation, epithelial-mesenchymal transition, and metastasis by targeting TWIST1 in non-small-cell lung cancer cells |
| Q39105277 | miR-335 suppresses migration and invasion by targeting ROCK1 in osteosarcoma cells |
| Q90352803 | miR-423 rs6505162 C>A polymorphism contributes to decreased Wilms tumor risk |
| Q90526172 | miR-608 and miR-4513 significantly contribute to the prognosis of lung adenocarcinoma treated with EGFR-TKIs |
| Q33731757 | miR-639 promotes the proliferation and invasion of breast cancer cell in vitro |
| Q39018734 | miRNA cargo within exosome-like vesicle transfer influences metastatic bone colonization. |
| Q36922253 | miRNA genetic alterations in human cancers |
| Q38602174 | miRNA profiling in gastrointestinal stromal tumors: implication as diagnostic and prognostic markers |
| Q40488561 | miRNA signature of schwannomas: possible role(s) of "tumor suppressor" miRNAs in benign tumors |
| Q39432311 | miRNAs and ovarian cancer: An overview |
| Q36967297 | miRNAs and their potential for use against cancer and other diseases |
| Q24628889 | miRNAs in human cancer |
| Q33827750 | miRNAs in human cancer. |
| Q38673891 | miRNAs in multiple myeloma--a survival relevant complex regulator of gene expression |
| Q38811968 | microRNA Expression Profiling: Technologies, Insights, and Prospects |
| Q36607817 | microRNA Regulation and Its Consequences in Cancer |
| Q36692329 | microRNA control of mouse and human pluripotent stem cell behavior |
| Q33588546 | microRNA expression patterns reveal differential expression of target genes with age. |
| Q37276128 | microRNA miR-196a-2 and breast cancer: a genetic and epigenetic association study and functional analysis |
| Q38021509 | microRNA regulation of cell viability and drug sensitivity in lung cancer |
| Q33893064 | microRNA signature and expression of Dicer and Drosha can predict prognosis and delineate risk groups in neuroblastoma |
| Q36084306 | microRNA-103 regulates the growth and invasion of endometrial cancer cells through the downregulation of tissue inhibitor of metalloproteinase 3. |
| Q37497239 | microRNA-181a has a critical role in ovarian cancer progression through the regulation of the epithelial-mesenchymal transition. |
| Q27693891 | microRNAs and RNA-binding proteins: a complex network of interactions and reciprocal regulations in cancer |
| Q36383144 | microRNAs as tumor inhibitors, oncogenes, biomarkers for drug efficacy and outcome predictors in lung cancer (review). |
| Q38336073 | microRNAs in breast cancer: regulatory roles governing the hallmarks of cancer |
| Q37592046 | microRNAs in gliomas: small regulators of a big problem |
| Q34717947 | microRNAs in viral oncogenesis |
| Q33344707 | microRNAs join the p53 network--another piece in the tumour-suppression puzzle |
| Q42653791 | microRNAs suppress cellular phenotypic heterogeneity |
| Q38638204 | microRNAs: An Emerging Paradigm in Lung Cancer Chemoresistance |
| Q51760786 | nc886 is induced by TGF-β and suppresses the microRNA pathway in ovarian cancer. |
| Q30424916 | p53 and microRNA-34 are suppressors of canonical Wnt signaling. |
| Q33719450 | p53-Responsive micrornas 192 and 215 are capable of inducing cell cycle arrest |
| Q37609205 | p62/SQSTM1 enhances breast cancer stem-like properties by stabilizing MYC mRNA. |
| Q36212703 | rs712 polymorphism within let-7 microRNA-binding site might be involved in the initiation and progression of colorectal cancer in Chinese population |
| Q38966763 | α-Solanine inhibits invasion of human prostate cancer cell by suppressing epithelial-mesenchymal transition and MMPs expression. |
| Q84774012 | “Micro”-managing the MiRNome in SzS |
Search more.